Document is current
Any future updates will be listed below
-
Authors
Langeveld, Mirjam https://orcid.org/0000-0002-9934-6831
Sirrs, Sandra
Lachman, Robin
Fazio, Timothy
Sharma, Reena
Ziagaki, Athanasia
Reismann, Peter
Tchan, Michel
Tran, Christel
van der Klauw, Melanie M.
Vassiliou, Daphne
Murphy, Elaine
- License Information
-
More Information
Article History
Received: 28 November 2025
Accepted: 22 April 2026
First Online: 2 June 2026
Declarations
:
: Not applicable.
: Mirjam Langeveld is involved in a pre-marketing PKU trial with Otsuka. AMC Research BV manages all financial arrangements. No fees, travel reimbursements, subsidies or grants, related to the presented work or otherwise, have been obtained from pharmaceutical companies. Elaine Murphy has received unrestricted educational grant funding from Nutricia UK for PKU-related projects and has been / is an investigator on clinical trials of new treatments for PKU (Maze Therapeutics; Biomarin Pharmaceuticals). Daphne Vassiliou has received research grants by Alnylam Pharmaceuticals. Sandra Sirrs, Robin Lachmann, Timothy Fazio, Reena Sharma, Athanasia Ziagaki, Peter Reismann, Michel Tchan, Melanie van der Klauw and Christel Tran have no competing interest to declare.
